Tenaya Therapeutics IncNASDAQ:TNYA
- LAST PRICE4.2100
- TODAY'S CHANGE (%)0.0300 (0.7177%)
- Bid / Lots3.8500/ 1
- Ask / Lots4.2800/ 1
- Open / Previous Close4.2100 / 4.1800
- Day Range
- 52 Week Range
- Volume301,019
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNYA |
|---|---|---|
| 09:32 ET | 569 | 4.21 |
| 09:41 ET | 800 | 4.22 |
| 09:43 ET | 2100 | 4.2 |
| 09:45 ET | 200 | 4.21 |
| 09:48 ET | 1338 | 4.245 |
| 09:50 ET | 1400 | 4.245 |
| 09:52 ET | 6253 | 4.17 |
| 09:54 ET | 3600 | 4.21 |
| 09:56 ET | 1100 | 4.21 |
| 09:57 ET | 250 | 4.21 |
| 09:59 ET | 700 | 4.21 |
| 10:08 ET | 100 | 4.195 |
| 10:14 ET | 400 | 4.21 |
| 10:19 ET | 300 | 4.19 |
| 10:21 ET | 100 | 4.19 |
| 10:26 ET | 3790 | 4.17 |
| 10:28 ET | 100 | 4.155 |
| 10:35 ET | 780 | 4.1346 |
| 10:39 ET | 100 | 4.145 |
| 10:42 ET | 4051 | 4.1644 |
| 10:50 ET | 100 | 4.145 |
| 10:51 ET | 100 | 4.145 |
| 10:53 ET | 300 | 4.145 |
| 10:55 ET | 100 | 4.145 |
| 11:06 ET | 100 | 4.145 |
| 11:08 ET | 124 | 4.16 |
| 11:11 ET | 100 | 4.17 |
| 11:15 ET | 800 | 4.155 |
| 11:18 ET | 1871 | 4.11 |
| 11:24 ET | 100 | 4.1 |
| 11:26 ET | 100 | 4.1 |
| 11:27 ET | 100 | 4.1 |
| 11:29 ET | 203 | 4.1047 |
| 11:31 ET | 100 | 4.1 |
| 11:36 ET | 300 | 4.1 |
| 11:40 ET | 100 | 4.1 |
| 12:00 ET | 884 | 4.09 |
| 12:03 ET | 100 | 4.1 |
| 12:09 ET | 500 | 4.075 |
| 12:18 ET | 1295 | 4.09 |
| 12:21 ET | 100 | 4.09 |
| 12:25 ET | 428 | 4.095 |
| 12:27 ET | 200 | 4.09 |
| 12:32 ET | 600 | 4.115 |
| 12:34 ET | 200 | 4.12 |
| 12:36 ET | 710 | 4.12 |
| 12:38 ET | 200 | 4.13 |
| 12:39 ET | 300 | 4.14 |
| 12:41 ET | 583 | 4.14 |
| 12:43 ET | 1133 | 4.13 |
| 12:45 ET | 400 | 4.12 |
| 12:48 ET | 500 | 4.13 |
| 12:50 ET | 200 | 4.13 |
| 12:52 ET | 1100 | 4.13 |
| 12:54 ET | 700 | 4.14 |
| 12:56 ET | 100 | 4.15 |
| 12:57 ET | 206 | 4.15 |
| 12:59 ET | 100 | 4.15 |
| 01:01 ET | 400 | 4.17 |
| 01:03 ET | 100 | 4.17 |
| 01:06 ET | 400 | 4.18 |
| 01:08 ET | 380 | 4.18 |
| 01:10 ET | 100 | 4.165 |
| 01:12 ET | 319 | 4.18 |
| 01:15 ET | 296 | 4.18 |
| 01:17 ET | 500 | 4.165 |
| 01:19 ET | 200 | 4.18 |
| 01:21 ET | 2393 | 4.14 |
| 01:24 ET | 100 | 4.13 |
| 01:26 ET | 1451 | 4.12 |
| 01:28 ET | 1981 | 4.14 |
| 01:30 ET | 200 | 4.15 |
| 01:32 ET | 400 | 4.17 |
| 01:35 ET | 400 | 4.17 |
| 01:37 ET | 364 | 4.17 |
| 01:42 ET | 100 | 4.155 |
| 01:44 ET | 400 | 4.17 |
| 01:46 ET | 1100 | 4.16 |
| 01:48 ET | 300 | 4.16 |
| 01:50 ET | 300 | 4.16 |
| 01:53 ET | 2126 | 4.14 |
| 01:55 ET | 3173 | 4.16 |
| 01:57 ET | 500 | 4.17 |
| 02:02 ET | 983 | 4.16 |
| 02:04 ET | 800 | 4.17 |
| 02:06 ET | 224 | 4.17 |
| 02:08 ET | 241 | 4.17 |
| 02:09 ET | 400 | 4.16 |
| 02:11 ET | 700 | 4.15 |
| 02:13 ET | 854 | 4.16 |
| 02:15 ET | 400 | 4.15 |
| 02:18 ET | 697 | 4.17 |
| 02:20 ET | 300 | 4.18 |
| 02:22 ET | 1214 | 4.18 |
| 02:24 ET | 100 | 4.185 |
| 02:26 ET | 600 | 4.2 |
| 02:27 ET | 500 | 4.18 |
| 02:29 ET | 500 | 4.16 |
| 02:31 ET | 300 | 4.18 |
| 02:33 ET | 235 | 4.18 |
| 02:36 ET | 200 | 4.18 |
| 02:38 ET | 300 | 4.17 |
| 02:40 ET | 200 | 4.18 |
| 02:42 ET | 300 | 4.18 |
| 02:45 ET | 599 | 4.19 |
| 02:47 ET | 700 | 4.17 |
| 02:49 ET | 2860 | 4.15 |
| 02:51 ET | 800 | 4.15 |
| 02:54 ET | 500 | 4.17 |
| 02:56 ET | 621 | 4.16 |
| 02:58 ET | 800 | 4.16 |
| 03:00 ET | 200 | 4.175 |
| 03:02 ET | 636 | 4.16 |
| 03:03 ET | 4176 | 4.17 |
| 03:05 ET | 500 | 4.15 |
| 03:07 ET | 544 | 4.17 |
| 03:09 ET | 500 | 4.18 |
| 03:12 ET | 300 | 4.18 |
| 03:14 ET | 400 | 4.17 |
| 03:16 ET | 686 | 4.18 |
| 03:18 ET | 414 | 4.16 |
| 03:20 ET | 400 | 4.18 |
| 03:21 ET | 867 | 4.18 |
| 03:23 ET | 1400 | 4.19 |
| 03:25 ET | 400 | 4.2 |
| 03:27 ET | 1100 | 4.2 |
| 03:30 ET | 2347 | 4.18 |
| 03:32 ET | 700 | 4.19 |
| 03:34 ET | 400 | 4.2 |
| 03:36 ET | 900 | 4.18 |
| 03:38 ET | 7627 | 4.18 |
| 03:39 ET | 2139 | 4.19 |
| 03:41 ET | 1027 | 4.19 |
| 03:43 ET | 1000 | 4.2 |
| 03:45 ET | 1589 | 4.2 |
| 03:48 ET | 5932 | 4.185 |
| 03:50 ET | 1404 | 4.2 |
| 03:52 ET | 5749 | 4.2 |
| 03:54 ET | 11089 | 4.2 |
| 03:56 ET | 8071 | 4.2 |
| 03:57 ET | 13349 | 4.2 |
| 03:59 ET | 20180 | 4.21 |
May 16, 2024
DJ Tenaya Therapeutics Is Maintained at Buy by Canaccord Genuity, from 12:10PM ET on Thursday May 16, 2024 by Dow Jones
12:10PM ET on Thursday May 16, 2024 by Dow Jones
May 15, 2024
DJ Tenaya Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co., from 12:03PM ET on Wednesday May 15, 2024 by Dow Jones
12:03PM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Tenaya Therapeutics Cutting Workforce by 22%, from 5:17PM ET on Tuesday May 14, 2024 by Dow Jones
5:17PM ET on Tuesday May 14, 2024 by Dow JonesTenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow JonesPress Release: Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by Dow Jones
4:05PM ET on Tuesday May 14, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tenaya Therapeutics Inc | 330.6M | -2.6x | --- |
Zura Bio Ltd | 334.3M | -3.2x | --- |
Skye Bioscience Inc | 325.9M | -2.6x | --- |
Ventyx Biosciences Inc | 337.0M | -1.5x | --- |
Replimune Group Inc | 323.7M | -1.6x | --- |
Fractyl Health Inc | 322.8M | -3.9x | --- |
Company Information
Tenaya Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. The Company is advancing a pipeline of novel therapies with diverse treatment modalities for rare genetic cardiovascular disorders and more prevalent heart conditions. The Company’s advanced product candidates include TN-201, TN-401, and TN-301. TN-201 is an adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed to treat the underlying cause of MYBPC3 associated HCM by delivering a working MYBPC3 gene to specific cells of the heart via a single infusion. TN-401 is the Company’s adeno-associated virus serotype 9 (AAV9)-based gene therapy being developed for the treatment of arrhythmogenic right ventricular cardiomyopathy (ARVC) due to disease-causing variants in the PKP2 gene. TN-301 is a small molecule for heart failure with preserved ejection fraction.
Contact Information
- Headquarters
- 171 Oyster Point Blvd., Suite 500SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-865-2066
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Goeddel
- Chief Executive Officer, Secretary
- Faraz Ali
- Chief Financial and Business Officer
- Leone Patterson
- Chief Scientific Officer
- Timothy Hoey
- Chief Medical Officer
- Whittemore Tingley
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $330.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 78.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.65 |
Book Value | $2.04 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
